Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Richter

Showing results (41-50 of 1,648) with videos related to

Pageof 165
Sort By:
Nucleic Acids Research|November 11, 1988
Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitroA Richter, U Strausfeld
Progress in Neurobiology|April 30, 1998
Pathology of idiopathic dystonia: findings from genetic animal modelsA Richter, W Löscher
European Journal of Pharmacology|April 1, 1994
The novel selective and silent 5-HT1A receptor antagonist (+)-WAY-100135 aggravates dystonic movements in a mutant hamster modelW Löscher, A Richter
Brain Research|November 28, 1997
MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamstersA Richter, W Löscher
European Journal of Pharmacology|May 4, 1999
Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosisA Richter, W Löscher
European Journal of Pharmacology|June 14, 2000
Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent modelA Richter, W Löscher
Nucleic Acids Research|February 25, 1990
Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cellsH Romig, A Richter
Experimental Cell Research|July 1, 1979
DNA replication during a serum-induced S phase in primate CV-1 cellsA Richter, R Hand
European Journal of Pharmacology|October 5, 1993
The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidolA Richter, W Löscher
European Journal of Internal Medicine|January 26, 2005
Chlamydia pneumoniae IgG and the severity of coronary atherosclerosisP Järemo, A Richter
Pageof 165

Showing results (41-50 of 1,648) with videos related to

Sort By:
Pageof 165
Nucleic Acids Research|November 11, 1988
Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitroA Richter, U Strausfeld
Progress in Neurobiology|April 30, 1998
Pathology of idiopathic dystonia: findings from genetic animal modelsA Richter, W Löscher
European Journal of Pharmacology|April 1, 1994
The novel selective and silent 5-HT1A receptor antagonist (+)-WAY-100135 aggravates dystonic movements in a mutant hamster modelW Löscher, A Richter
Brain Research|November 28, 1997
MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamstersA Richter, W Löscher
European Journal of Pharmacology|May 4, 1999
Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosisA Richter, W Löscher
European Journal of Pharmacology|June 14, 2000
Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent modelA Richter, W Löscher
Nucleic Acids Research|February 25, 1990
Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cellsH Romig, A Richter
Experimental Cell Research|July 1, 1979
DNA replication during a serum-induced S phase in primate CV-1 cellsA Richter, R Hand
European Journal of Pharmacology|October 5, 1993
The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidolA Richter, W Löscher
European Journal of Internal Medicine|January 26, 2005
Chlamydia pneumoniae IgG and the severity of coronary atherosclerosisP Järemo, A Richter
Pageof 165